| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 03/18/1987 | EP0214924A2 Oxytocin and antigestagene for the induction of labour |
| 03/18/1987 | EP0214640A2 Monoclonal antibody in relation to drug-resistant cancers and production thereof |
| 03/18/1987 | EP0214620A2 Transdermal application form of diltiazem |
| 03/17/1987 | US4650785 Pharmaceutical composition having an excellent absorption property |
| 03/17/1987 | CA1219218A1 Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it |
| 03/12/1987 | WO1986003125A3 Use of purified lipopolysaccharides and their derivatives |
| 03/11/1987 | EP0213811A2 Bateriocin-Targeted compounds for cancer therapy |
| 03/11/1987 | EP0213523A2 Pharmaceutical compositions containing acylated phospholipids |
| 03/05/1987 | DE3531597A1 Use of preparations containing interferon-gamma (IFN-gamma) for the treatment of psoriatic disorders |
| 03/04/1987 | EP0212927A1 Pharmaceutical composition comprising sodium cromoglycate and a mucolytic agent |
| 03/04/1987 | EP0212647A2 Cardiotonic phosphodiesterase inhibitors complexed with water soluble vitamins |
| 02/25/1987 | EP0211434A2 Rectal dosage forms for ceftriaxone |
| 02/25/1987 | EP0211354A2 Nucleosides and their use as antineoplastic agents |
| 02/25/1987 | CN86105639A Rectal dosage forms |
| 02/04/1987 | EP0210759A2 Suppositories containing analgesics, antipyretics or anti-inflammatory agents |
| 02/03/1987 | CA1217429A1 Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same |
| 01/27/1987 | US4639435 Pharmaceutical composition suitable for intestinal administration |
| 01/27/1987 | CA1217141A1 Norepinephrine potentiated compositions and method of use |
| 01/24/1987 | CN85101697A Dihydropyridine combination preparations and process for their preparation |
| 01/21/1987 | EP0209030A2 Use of tumour necrosis factor in the preparation of pharmaceutical compounds |
| 01/15/1987 | WO1987000055A1 Antiglaucoma compositions |
| 01/15/1987 | WO1987000047A1 Method and composition for the treatment of chronic obstructive pulmonary disease |
| 01/14/1987 | EP0208617A1 Controlled drug device and process for catalysing the erosion of an acid labile polymer |
| 01/14/1987 | CN85106098A Biodeodorizer and the process thereof |
| 01/13/1987 | CA1216592A1 Food compositions containing fatty substances and a process for the preparation thereof |
| 01/10/1987 | CN85101820A Nifedipine combination preparations and process for their preparation |
| 01/07/1987 | EP0207624A2 Method for preparing infection-resistant materials |
| 01/02/1987 | DE3522572A1 Composition for the protection and treatment of the skin |
| 12/30/1986 | EP0206741A2 Leukotriene antagonists |
| 12/30/1986 | EP0206627A2 Methods for the treatment of gastrointestinal disorders |
| 12/30/1986 | EP0206626A2 Use of Bismuth for the manufacture of a medicament for the treatment of gastrointestinal disorders induced by Campylobacter polyridis |
| 12/30/1986 | EP0206625A2 Compositions for the treatment of gastrointestinal disorders |
| 12/17/1986 | EP0205387A2 Human monocytes cultured in suspension in serum-free medium |
| 12/17/1986 | EP0204987A1 Medicine containing vitamin E for improving the properties of blood |
| 12/17/1986 | EP0204954A2 Use of dopamine agonists for the manufacture of a medicament for the treatment of psychostimulant addiction |
| 12/17/1986 | EP0204951A2 Use of calcium channel blockers in the production of compositions for withdrawal symptoms |
| 12/10/1986 | EP0204447A2 Pharmaceutical preparations which may be used for stimulating tear secretion |
| 12/10/1986 | EP0204129A2 Use of calcium channel blockers in the production of compositions for reconstructive surgery |
| 12/03/1986 | EP0203157A1 Use of purified lipopolysaccharides and their derivatives |
| 12/02/1986 | US4626531 Prostaglandins and antigestagens for induction of labor and for abortion |
| 11/26/1986 | EP0202642A2 Process for the in vitro immunization of human splenocytes against tumor associated antigens |
| 11/25/1986 | US4625019 Polymeric product of daunorubicin and glutaraldehyde |
| 11/25/1986 | US4625014 Cell-delivery agent |
| 11/20/1986 | EP0202065A2 Polymer, production and use thereof |
| 11/12/1986 | EP0201219A1 Growth-promoting compositions |
| 11/05/1986 | EP0200490A2 Compositions for noninvasive administration of sedatives, analgesics, and anesthetics |
| 11/05/1986 | EP0200412A2 Method of conferring immunotolerance to a specific antigen |
| 11/05/1986 | EP0200169A2 Pharmaceutical composition for cure and prevention of cardiovascular disease and method of preparing the same |
| 10/28/1986 | US4619934 Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs |
| 10/28/1986 | US4619913 Treatments employing drug-containing matrices for introduction into cellular lesion areas |
| 10/28/1986 | US4619829 Utilization of a single vitamin or a combination of various vitamins |
| 10/28/1986 | US4619827 Method for administering equine vaccines and compositions therefor |
| 10/28/1986 | CA1213229A1 Antibodies having dual specificities, their preparation and uses therefor |
| 10/21/1986 | US4618492 Crosslinking agents that permit controlled release of amino-group-containing substances under mildly acidic conditions |
| 10/15/1986 | EP0197718A2 New medicaments for topical use |
| 10/15/1986 | EP0197435A2 Choriocarcinoma monoclonal antibodies and antibody panels |
| 10/08/1986 | EP0196434A1 Process for the preparation of a composition based on a divided substance with a slight hydrosolubility |
| 09/17/1986 | EP0194901A2 Isoprenoidamine derivatives, compositions containing them, their preparation, and their use |
| 09/17/1986 | EP0194880A2 Multivitamin preparation |
| 09/17/1986 | EP0194794A2 Saccharide digestion inhibiting composition |
| 09/17/1986 | CN86101476A Preparation of a composition based on a finely divided active principle of low water solubility |
| 09/16/1986 | US4612337 Method for preparing infection-resistant materials |
| 09/16/1986 | CA1211374A1 Pharmaceutical compositions containing more active ingredients |
| 09/12/1986 | WO1986005098A1 Immunotoxin and method of making |
| 09/03/1986 | EP0193400A2 Pharmaceutical compositions |
| 09/03/1986 | EP0193161A2 Antibody hybrid molecules and process for their preparation |
| 09/03/1986 | EP0192667A1 Device for initiating reperfusion treatment when heart attack symptoms are present. |
| 08/27/1986 | EP0192002A1 Prolonged acting immunotoxins comprising a ribosome inactivating glycopeptide constituent having modified polyssaccharide moieties |
| 08/27/1986 | EP0191771A1 Automatic injector assembly. |
| 08/19/1986 | CA1209906A1 Pharmaceutical composition suitable for intestinal administration |
| 08/14/1986 | WO1986003751A3 Purification, production and use of tumor necrosis factors |
| 08/13/1986 | EP0190315A1 Dehydrated liposomes. |
| 08/12/1986 | US4605552 Diltiazem |
| 08/06/1986 | EP0190050A2 Method for preparing small vesicles using microemulsification |
| 08/06/1986 | EP0189788A1 Synergistic combination of flupirtin and non-steroidal anti-phlogistics |
| 08/05/1986 | CA1209047A1 Therapeutic composition containing piracetam analog |
| 07/30/1986 | EP0189336A1 Pharmaceutical compositions containing an alpha-blocker and a calcium antagonist |
| 07/30/1986 | EP0189002A2 Treatment of gastrointestinal disorders using 5-HT3 antagonists |
| 07/30/1986 | EP0188595A1 A drug kit or drug composition for use in preventing and treating ischaemic cell damage and preparation thereof |
| 07/16/1986 | EP0187547A2 Synthetic polymeric drugs |
| 07/08/1986 | US4599342 Mixture of capsaicin with opioid |
| 07/08/1986 | US4599340 Enhanced soft tissue flap survival in reconstructive surgery |
| 07/03/1986 | WO1986003751A2 Purification, production and use of tumor necrosis factors |
| 07/02/1986 | EP0186551A1 Medicament containing as a mixture at least one immunotoxin and at least one polymer containing mannose |
| 07/01/1986 | US4598072 Combinations of an aromatase-inhibitor and an antiandrogen for prophylaxis and/or treatment of benign prostatic hyperplasia |
| 06/17/1986 | CA1206096A1 Synthetic whole blood substitute and process for preparing the same |
| 06/11/1986 | EP0184471A1 Product containing an antiprogestomimetic and a uterotonic substance |
| 06/10/1986 | CN85108498A Hair growth modification |
| 06/05/1986 | WO1986003125A2 Use of purified lipopolysaccharides and their derivatives |
| 05/27/1986 | US4591503 Composition for improved absorption of 2A cations and gold comprising yeast or Lactobacillus |
| 05/27/1986 | CA1205031A1 Hyaluronic acid fractions having pharmaceutical activity, and processes for the preparation thereof |
| 05/21/1986 | EP0181455A2 Use of preparations containing interferon-gamma (IFN-gamma) for systematically treating various human diseases at a low dosage |
| 05/21/1986 | EP0181351A1 A method for the modulation of the immune response |
| 05/14/1986 | EP0180878A2 Heterodimeric T lymphocyte receptor |
| 05/14/1986 | EP0180737A2 Use of interferon gamma (IFN-gamma) for the production of preparations for treating rheumatic diseases |
| 05/13/1986 | CA1204385A1 Concentrated hydrosols containing lipophilic and hydrophilic vitamins and process for their preparationpreparation |
| 05/07/1986 | EP0180564A2 Immunogenic complex, a method for producing the same, and the use thereof as an immune stimulant, vaccines and reagents |
| 05/06/1986 | US4587268 Bone disorders |
| 05/06/1986 | US4587249 Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same |
| 04/30/1986 | EP0179062A1 Prophylaxis and therapy of coronary heart diseases by lowering the estrogen concentration |